Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Some 59% of patients respond so well to this therapy that adjuvant treatment is no longer needed, according to the results ...
Jun 3, 2024
0
1
How can someone have alcohol intoxication without consuming alcohol? Auto-brewery syndrome, a rare condition in which gut fungi create alcohol through fermentation, is described in a case study in the Canadian Medical Association ...
Jun 3, 2024
0
1
Aneuploidy (the presence of an abnormal number of chromosomes) in embryos is a major cause of impaired embryo development, leading to conditions such as Down syndrome, as well as to pregnancy loss. The transfer of such embryos ...
Jun 3, 2024
0
0
Twenty-six years. That is roughly how much of our lives are spent asleep. Scientists have been trying to explain why we spend so much time sleeping since at least the ancient Greeks, but pinning down the exact functions of ...
Jun 2, 2024
0
26
An international team of medical researchers has developed a protein-based risk score for hip fracture using an aptamer-based proteomic platform. In their study, published in the journal Nature Aging, the group analyzed data ...
Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia—elevations of triglycerides and cholesterol.
May 28, 2024
0
33
Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease, shows a new international study led by the University of Turku and Turku University Hospital in Finland. Caffeine consumption ...
May 28, 2024
0
10
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern ...
May 23, 2024
0
37
Celery, a major cause of vegetable allergies, carries the risk of causing severe allergic reactions, especially in individuals with mugwort pollen sensitization.
May 23, 2024
0
0
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug—dupilumab—that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers ...
May 20, 2024
0
17
